Filing Details

Accession Number:
Form Type:
Zero Holdings:
Publication Time:
2010-01-13 12:00:00
Reporting Period:
Filing Date:
Accepted Time:
2010-01-13 19:39:47
SEC Url:
Form 4 Filing
Cik Name Symbol Sector (SIC) IRS No
914475 Neurocrine Biosciences Inc NBIX Biological Products, (No Disgnostic Substances) (2836) 330525145
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1123346 E Margaret Jensen Valeur Neurocrine Biosciences, Inc.
12780 El Camino Real
San Diego CA 92130
Evp And General Counsel No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2010-01-12 8,697 $2.52 72,399 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
  1. Sale of 8,697 shares of common stock issued upon vesting of 19,334 restricted stock units on January 11, 2010 to cover payroll and withholding taxes, with the balance of the shares (10,637) maintained by the Reporting Person; the sale was affected by a broker pursuant to instructions set forth in a Rule 10b5-1 plan adopted by the Reporting Person and delivered to the broker on May 26, 2009.
  2. Represents a weighted average sales price per share. The prices actually received ranged from $2.50 to $2.57. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.